5-FU, as a commonly used chemotherapy drug for colorectal cancer, has been reported to upregulate the expression of DR5 in cells through p53, inducing the activation of exogenous apoptosis signaling pathways (Longley et al., 2006; Yu et al., 2013). Here, TNFRSF10B is linked to colorectal cancer.